Diagnostic Accuracy of ShuntCheck Compared to Radionuclide Shunt: Patency in Patients With Normal Pressure Hydrocephalus
1 other identifier
observational
20
1 country
1
Brief Summary
The purpose of this study is to assess the diagnostic accuracy of ShuntCheck compared with radionuclide shunt patency testing (SPS) to detect CSF shunt flow of NPH patients with suspected shunt obstruction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 24, 2020
CompletedFirst Submitted
Initial submission to the registry
March 12, 2020
CompletedFirst Posted
Study publicly available on registry
March 16, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2025
CompletedJune 1, 2022
May 1, 2022
4.4 years
March 12, 2020
May 30, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Sensitivity of ShuntCheck compared to radionuclide shunt patency study
15 minutes
Negative Predictive Value of ShuntCheck compared to radionuclide shunt patency study
60 Minutes
Study Arms (1)
ShuntCheck
Participants will be administered the ShuntCheck diagnostic test.
Interventions
The intervention is an FDA-cleared device utilizing a transcutaneous thermal convection to analyze shunt flow.
Eligibility Criteria
The study population will consist of NPH hydrocephalus research subjects who have a VP shunt with a single ventricular catheter implanted for adult hydrocephalus are suspected of shunt obstruction and are scheduled for a radionuclide SPS.
You may qualify if:
- Men or women 40 yo or older and have a VP shunt placed for NPH and are suspected of shunt obstruction.
- Capable of providing valid signed informed consent, or has a legal guardian, health care agent, or surrogate decision maker (according to local statutes, and collectively referred to as "surrogates" in this protocol) capable of providing valid, signed informed consent
You may not qualify if:
- Presence of multiple shunts, or presence of more than one distal shunt catheter (regardless of function) crossing the clavicle ipsilateral to the shunt with suspected obstruction;
- ShuntCheck test would interfere with standard patient care, or emergency shunt surgery that cannot be delayed is indicated;
- Presence of an interfering open wound or edema over any portion of the VP shunt.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of South Floridalead
- NeuroDx Developmentcollaborator
Study Sites (1)
University of South Florida Department of Neurological Surgery and Brain Repair
Tampa, Florida, 33606, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Naomi Abel, MD
University of South Florida
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor, College of Medicine Neurosurgery
Study Record Dates
First Submitted
March 12, 2020
First Posted
March 16, 2020
Study Start
January 24, 2020
Primary Completion
June 1, 2024
Study Completion
January 1, 2025
Last Updated
June 1, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will not share
At present there is no plan to share any individual participant data.